Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 5 minute read Pharma Industry News Hypertension breakthrough: Scienture launches first FDA-approved liquid losartan Arbli through U.S. distributors Discover how Scienture’s Arbli is redefining hypertension treatment as the first FDA-approved liquid losartan and what it signals for SCNX investors. bySoujanya RaviOctober 16, 2025